Parkinsons plus syndromes
Definition: Parkinson’s plus syndromes are a group of neurodegenerative disorders that present with parkinsonism plus additional neurological features and show poor or transient response to levodopa, unlike classic Parkinson disease.
Main Types
1. Progressive Supranuclear Palsy (PSP)
Pathology: Tau protein accumulation → brainstem degeneration
Clinical Features
- Early postural instability and falls (backward falls)
- Vertical gaze palsy (especially downward gaze)
- Axial rigidity > limb rigidity
- Dysarthria, dysphagia
- Cognitive impairment (frontal dementia)
Key Sign: “Staring face” + inability to look down
2. Multiple System Atrophy (MSA)
Subtypes: MSA-P (parkinsonian type). MSA-C (cerebellar type)
Clinical Features: Parkinsonism (poor levodopa response). Cerebellar ataxia (MSA-C)
Severe autonomic failure: Orthostatic hypotension. Urinary incontinence/retention. Erectile dysfunction
Key Sign: Early autonomic dysfunction is hallmark
3. Corticobasal Degeneration (CBD)
Clinical Features: Asymmetric rigidity and bradykinesia. Apraxia. “Alien limb phenomenon”. Cortical sensory loss. Myoclonus
Key Sign: One limb behaves “independently”
4. Dementia with Lewy Bodies (DLB)
(Overlap between dementia and parkinsonism)
Clinical Features: Dementia occurs early. Visual hallucinations (vivid, recurrent). Parkinsonism (mild/moderate). Fluctuating cognition
Key Sign: Early dementia + hallucinations + parkinsonism
Comparison with Parkinson Disease
Clinical Clues for Diagnosis
“Red Flags” for atypical parkinsonism: Early falls. Early dementia. Severe autonomic. dysfunction. Poor response to levodopa. Rapid progression
Examination Findings
- General Parkinsonism Signs: Bradykinesia. Rigidity. Postural instability
- Additional Syndrome-Specific Signs
- PSP → vertical gaze palsy
- MSA → autonomic failure
- CBD → apraxia, alien lim
- DLB → hallucinations, fluctuating cognition
Diagnosis
Clinical Diagnosis (most important): Based on pattern recognition + atypical features
Imaging
MRI may show:
- PSP: midbrain atrophy (“hummingbird sign”)
- MSA: pontocerebellar atrophy (“hot cross bun sign”)
- CBD: asymmetric cortical atrophy
Treatment
- General: Poor response to levodopa. Symptomatic treatment only
- Symptomatic Management: Physiotherapy. Speech therapy. Autonomic symptom management (MSA). Cognitive support (DLB)